Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.12 | 1.63 |
NAV | ₹9.85 | ₹1042.41 |
Fund Started | 11 Nov 2024 | 04 Jun 1998 |
Fund Size | ₹81.24 Cr | ₹26939.23 Cr |
Exit Load | - | Exit load of 1% if redeemed within 1 month. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -3.52% | 9.16% |
3 Year | - | 20.34% |
5 Year | - | 23.29% |
1 Year
3 Year
5 Year
Equity | 100.00% | 94.67% |
Cash | 0.00% | 4.39% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 4.39% |
Sun Pharmaceutical Industries Ltd. | 4.36% |
ICICI Bank Ltd. | 4.24% |
Apollo Hospitals Enterprise Ltd. | 4.18% |
Bharti Airtel Ltd. | 4.17% |
ITC Ltd. | 4.03% |
HDFC Life Insurance Co Ltd. | 3.93% |
Bajaj Finance Ltd. | 3.88% |
Britannia Industries Ltd. | 3.84% |
SBI Life Insurance Company Ltd. | 3.80% |
Name | Assets |
|---|---|
Axis Bank Ltd. | 4.95% |
SBI Cards And Payment Services Ltd. | 4.41% |
FSN E-Commerce Ventures Ltd. | 3.64% |
Maruti Suzuki India Ltd. | 3.60% |
ICICI Bank Ltd. | 3.35% |
Sona BLW Precision Forgings Ltd. | 3.04% |
Indusind Bank Ltd. | 2.90% |
Page Industries Ltd. | 2.49% |
Infosys Ltd. | 2.46% |
Alkem Laboratories Ltd. | 2.37% |
Name | Sharwan Kumar Goyal | Ihab Dalwai |
Start Date | 28 Jan 2025 | 06 May 2025 |
Name
Start Date
Description | The scheme seeks to provide returns that, before expenses, corresponds to the total return of the securities as represented by the underlying index, subject to tracking error. | The scheme seeks to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of large-cap and mid-cap companies. |
Launch Date | 11 Nov 2024 | 04 Jun 1998 |
Description
Launch Date